Dr. Qifang Li is a Chief Physician and Doctoral Supervisor at Shanghai Fourth People’s Hospital affiliated with Tongji University School of Medicine. He holds a Doctor of Medicine degree in Anesthesiology from Shanghai Jiao Tong University School of Medicine, with a subspecialty in Sleep Medicine. With over 20 years of clinical and research experience, Dr. Li has completed a two-year research fellowship at the University of Washington in the United States. His research primarily focuses on anesthesiology, neuroprotection, hypoxia-inducible factors, and the mechanisms underlying inflammatory and neurodegenerative responses. Dr. Li has published over 20 SCI-indexed papers as lead or corresponding author in high-impact journals and holds one utility model patent. He is also the chief editor of a Traditional Chinese Medicine monograph and actively serves on professional committees in anesthesiology and pain medicine. Dr. Li has received multiple prestigious awards, including the Shanghai Excellent Doctoral Dissertation Award, the Shanghai Science and Technology Award (First Prize), and funding under programs such as the Pujiang Talent Plan and the National Distinguished Young Scientists Program.
-
Qifang Li holds a Doctor of Medicine degree in Anesthesiology from Shanghai Jiao Tong University School of Medicine, which he earned in July 2007. His postgraduate training focused on sleep medicine within the field of anesthesia. As of July 2023, he is also a doctoral supervisor, contributing to academic leadership and mentoring in medical education.
👨🏫 Experience
-
Dr. Qifang Li currently serves as a Chief Physician at Shanghai Fourth People’s Hospital, affiliated with the School of Medicine at Tongji University. He has also gained valuable international experience, having spent two years engaged in research and clinical exchange at the University of Washington in the United States. With over two decades of clinical and research experience, he has played a pivotal role in integrating anesthesiology with sleep medicine and advancing translational research in related fields.
🤝Awards and Honors
-
Dr. Li has received numerous accolades throughout his career, including the prestigious Shanghai Excellent Doctoral Dissertation Award in 2008. He has been selected for several highly competitive talent programs such as the Rising Star Program (启明星计划), the New World Excellent Talent Program, the Leading Talent Program, the Thousand Talents Program, the Hundred Talents Program, and the Pujiang Talent Program. Notably, he was awarded first prize in the Shanghai Science and Technology Awards in 2016.
💡Skills and Certifications
-
In addition to his clinical and research skills, Dr. Li has demonstrated leadership in academic publishing, clinical teaching, and professional service. He has contributed to medical education as the chief editor of a Chinese medicine monograph titled Tan Pai Zhong Yi, published by Science Press in January 2017. Dr. Li also holds a national utility model patent, reflecting his interest in medical innovation. He actively participates in academic exchange as a member of the third committee of the Shanghai Pain Society and as a youth member of China’s inaugural Combined Chinese-Western Anesthesia and Pain Medicine Committee.
🔬 Research Focus
-
Dr. Li’s research centers on anesthesiology, sleep medicine, and neuroinflammation, with a strong emphasis on the role of hypoxia-inducible factors (HIFs), isoflurane, and neuroprotection. His work has explored the molecular mechanisms underlying anesthesia-induced neurotoxicity, lung injury caused by trauma or hemorrhagic shock, and the modulation of immune responses through anesthetic agents. More recently, he has studied the application of anesthetics in dermatological diseases such as psoriasis, contributing novel findings on the therapeutic roles of lidocaine and scopolamine.
🌎Conclusion
-
Dr. Qifang Li is an outstanding candidate for the Research for Best Researcher Award due to their impactful, interdisciplinary research in anesthesiology and chronic disease management. Their innovative use of epidural lidocaine therapy demonstrates a strong commitment to improving patient outcomes. With consistent high-quality publications and real-world clinical relevance, Dr. Li exemplifies excellence in translational medical research. Their work significantly advances both scientific knowledge and clinical practice.
📖Publications
-
The 95% effective dose of dexmedetomidine to induce adequate sedation in patients with chronic insomnia disorder: a biased coin design up-and-down sequential allocation trial
Authors: M. Li, G. Li, Q. Li, Q. Cai
Journal: BMC Anesthesiology (2024)
-
Epidural block with lidocaine ameliorates kidney function deterioration and fibrosis of chronic kidney disease in rats
Authors: X. Xu, B. Yu, Y. Lv, S. Chen, Q. Li
Journal: American Journal of the Medical Sciences (2024)
-
Case report: Successful reversal of chronic kidney disease by epidural block with lidocaine
Authors: X. Qiu, B. Su, Q. Li
Journal: Journal of Anesthesia and Translational Medicine (2024)
-
Efficacy and safety of epidural block with lidocaine for refractory severe plaque psoriasis: An open-label pilot study in real world setting
Authors: X. Xu, B. Yu, Y. Lv, G. Li, Q. Li
Journal: Journal of Dermatology (2024)